401.87
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$399.55
Aprire:
$403.7
Volume 24 ore:
297.63K
Relative Volume:
1.58
Capitalizzazione di mercato:
$5.53B
Reddito:
$2.53B
Utile/perdita netta:
$265.24M
Rapporto P/E:
21.88
EPS:
18.3669
Flusso di cassa netto:
$325.48M
1 W Prestazione:
-1.47%
1M Prestazione:
-15.08%
6M Prestazione:
-9.98%
1 anno Prestazione:
-31.88%
Chemed Corp Stock (CHE) Company Profile
Nome
Chemed Corp
Settore
Industria
Telefono
(513)762-6690
Indirizzo
SUITE 2600, CINCINNATI, OH
Compare CHE vs HCA, THC, FMS, ENSG, UHS
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
CHE
Chemed Corp
|
401.87 | 5.53B | 2.53B | 265.24M | 325.48M | 18.37 |
|
HCA
Hca Healthcare Inc
|
532.97 | 119.18B | 75.60B | 7.78B | 7.69B | 28.38 |
|
THC
Tenet Healthcare Corp
|
227.63 | 19.80B | 21.31B | 2.37B | 2.53B | 15.49 |
|
FMS
Fresenius Medical Care Ag Adr
|
22.79 | 12.73B | 22.18B | 1.36B | 2.00B | 1.9216 |
|
ENSG
Ensign Group Inc
|
209.71 | 12.19B | 5.06B | 344.26M | 370.71M | 5.8446 |
|
UHS
Universal Health Services Inc
|
192.42 | 11.75B | 17.36B | 1.51B | 849.25M | 23.15 |
Chemed Corp Stock (CHE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-27 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2026-01-22 | Downgrade | Jefferies | Buy → Hold |
| 2025-09-02 | Aggiornamento | Jefferies | Hold → Buy |
| 2025-07-25 | Iniziato | Jefferies | Hold |
| 2020-03-11 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2019-11-01 | Aggiornamento | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-09-06 | Reiterato | BofA/Merrill | Buy |
| 2018-10-12 | Iniziato | BofA/Merrill | Buy |
| 2017-08-28 | Iniziato | KeyBanc Capital Mkts | Sector Weight |
| 2016-11-01 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2016-07-27 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2016-05-02 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2015-10-26 | Reiterato | Oppenheimer | Outperform |
| 2015-10-26 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2015-09-22 | Reiterato | Oppenheimer | Outperform |
| 2015-07-27 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2015-02-19 | Reiterato | Oppenheimer | Outperform |
| 2014-09-23 | Reiterato | Oppenheimer | Outperform |
| 2014-06-10 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2014-05-01 | Reiterato | Oppenheimer | Outperform |
| 2013-09-10 | Reiterato | Deutsche Bank | Hold |
| 2011-03-04 | Reiterato | Barclays Capital | Underweight |
| 2011-02-17 | Reiterato | Oppenheimer | Outperform |
| 2011-02-17 | Reiterato | RBC Capital Mkts | Sector Perform |
Mostra tutto
Chemed Corp Borsa (CHE) Ultime notizie
Chemed (NYSE:CHE) CEO Sells $806,360.00 in Stock - MarketBeat
Chemed (CHE) CEO Kevin McNamara sells 2,000 shares, retains 93,719 - Stock Titan
Chemed Corporation to Present at the Oppenheimer 36th Annual Healthcare Conference - Bluefield Daily Telegraph
First Trust Advisors LP Grows Stock Position in Chemed Corporation $CHE - MarketBeat
Chemed: Expanding Hospice Reach Through Strategic Certificate Of Need Wins In Florida! - Smartkarma
Chemed (NYSE:CHE) Lowered to "Strong Sell" Rating by Zacks Research - MarketBeat
Technical Reactions to CHE Trends in Macro Strategies - Stock Traders Daily
Chemed Corporation $CHE Shares Sold by Segall Bryant & Hamill LLC - MarketBeat
CHE Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Chemed Corporation $CHE Shares Purchased by Bahl & Gaynor Inc. - MarketBeat
Chemed Corporation Receives 'Hold' Rating from Analysts - National Today
Chemed Corp. Stock Hits Day Low of $385 Amid Price Pressure - Markets Mojo
Chemed Corp (CHE) Stock Analysis: Navigating A Stable Healthcare Giant with 8% Upside Potential - DirectorsTalk Interviews
Chemed Corporation (NYSE:CHE) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Chemed Corp. Faces Weak Start with 14% Gap Down Amid Market Concerns - Markets Mojo
Chemed Corp. Stock Plummets to New 52-Week Low at $385.00 - Markets Mojo
CHE Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Chemed Q4 Earnings Call Highlights - Yahoo Finance
CHE Stock Falls Post Q4 Earnings & Revenue Miss, Margins Crash - Yahoo Finance
Chemed Corporation (NYSE:CHE) Q4 2025 Earnings Call Transcript - Insider Monkey
RBC Capital cuts Chemed stock rating on Roto-Rooter margin concerns By Investing.com - Investing.com South Africa
RBC Capital cuts Chemed stock rating on Roto-Rooter margin concerns - Investing.com
Earnings call transcript: Chemed Corp misses Q4 2025 estimates, stock drops By Investing.com - Investing.com South Africa
Chemed Corp stock hits 52-week low at 397.05 USD By Investing.com - Investing.com Australia
Chemed Corporation Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses - GlobeNewswire Inc.
Why Chemed (CHE) Shares Are Plunging Today - Yahoo Finance
Chemed (CHE) Q4 2025 Earnings Call Transcript - AOL.com
Earnings call transcript: Chemed Corp misses Q4 2025 estimates, stock drops - Investing.com
VITAS Takes a Punch in Q4 2025, Expects Brighter 2026 - Hospice News
Chemed (NYSE:CHE) Reaches New 52-Week Low After Earnings Miss - MarketBeat
BofA downgrades Chemed stock rating on weaker Roto-Rooter outlook By Investing.com - Investing.com Canada
BofA downgrades Chemed stock rating on weaker Roto-Rooter outlook - Investing.com
Chemed Corp stock hits 52-week low at 397.05 USD - Investing.com
Chemed Corporation Q4 2025 Earnings Call Summary - Yahoo Finance
TD Asset Management Inc Has $135.14 Million Stake in Chemed Corporation $CHE - MarketBeat
Chemed: Fourth Quarter Earnings Overview - Bitget
Chemed (NYSE:CHE) Updates FY 2026 Earnings Guidance - MarketBeat
Chemed Corp reports results for the quarter ended December 31Earnings Summary - TradingView
Chemed (NYSE:CHE) Reports Sales Below Analyst Estimates In Q4 CY2025 Earnings, Stock Drops 14.7% - Finviz
Chemed: Q4 Earnings Snapshot - Barchart.com
Chemed Corp. Profit Retreats In Q4 - Nasdaq
Chemed Corp (CHE) Releases Q4 2025 Earnings: Revenue Slightly Down, EPS Miss and Operating Cash Decline - Quiver Quantitative
Chemed Corporation Reports Fourth Quarter 2025 Financial Results, Highlights Performance in VITAS and Roto-Rooter Segments - Quiver Quantitative
Hospice and plumbing under one roof: how Chemed plans to lift 2026 profits - Stock Titan
Chemed earnings on deck: Can hospice rebound ease Roto-Rooter woes? - Investing.com India
Chemed earnings on deck: Can hospice rebound ease Roto-Rooter woes? By Investing.com - Investing.com South Africa
Chemed (CHE) To Report Earnings Tomorrow: Here Is What To Expect - Finviz
Chemed Corp (CHE) Stock Analysis: Healthcare Service Leader Eyes 16.85% Potential Upside - DirectorsTalk Interviews
Chemed Corp - Reuters
Trading the Move, Not the Narrative: (CHE) Edition - Stock Traders Daily
Chemed Corporation (NYSE:CHE) Announces Quarterly Dividend of $0.60 - MarketBeat
Chemed Corp Azioni (CHE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):